SSL medical products disposal "well underway":
This article was originally published in Clinica
In a trading update, UK healthcare firm SSL International said the process of disposing of its medical products division was now well underway. At the end of March 2003, the company appointed Rothschild to oversee the sale of the division, which sells surgical gloves and products for wound management and compression therapy (see Clinica No 1052, p 15). Its sales totalled £197m ($315m) in the year ended March 31, up by 7% on a reported level but flat in underlying terms after a difficult year for surgical gloves. Total group sales were £622m.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.